Back
Phathom Pharmaceuticals Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
PHAT
Phathom Pharmaceuticals
Last Price:
$4.24
Seasonality Move:
17.73%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing slight buying pressure.
Phathom Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.62 | Sell |
20-day SMA: | 5.58 | Sell |
50-day SMA: | 5.76 | Sell |
200-day SMA: | 10.8 | Sell |
8-day EMA: | 5.38 | Sell |
20-day EMA: | 5.61 | Sell |
50-day EMA: | 6.13 | Sell |
200-day EMA: | 9.12 | Sell |
Phathom Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.15 | Sell |
Relative Strength Index (14 RSI): | 40.69 | Sell |
Chaikin Money Flow: | 271874 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.85 - 6.31) | Sell |
Bollinger Bands (100): | (5.06 - 9.36) | Sell |
Phathom Pharmaceuticals Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Phathom Pharmaceuticals Stock
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 4.87 while PHAT 8-day simple moving average is 5.62, which is a Sell signal.
-
The stock price of PHAT is 4.87 while Phathom Pharmaceuticals 20-day SMA is 5.58, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day simple moving average is 5.76 while PHAT share price is 4.87, making it a Sell technically.
-
PHAT stock price is 4.87 and Phathom Pharmaceuticals 200-day simple moving average is 10.80, creating a Sell signal.
PHAT Technical Analysis vs Fundamental Analysis
Sell
13
Phathom Pharmaceuticals (PHAT)
is a Sell
Is Phathom Pharmaceuticals a Buy or a Sell?
-
Phathom Pharmaceuticals stock is rated a SellThe current Phathom Pharmaceuticals [PHAT] share price is $4.87. The Score for PHAT is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
Phathom Pharmaceuticals Stock Info
Market Cap:
338.4M
Price in USD:
4.87
Share Volume:
792K
Phathom Pharmaceuticals 52-Week Range
52-Week High:
19.71
52-Week Low:
4.07
Sell
13
Phathom Pharmaceuticals (PHAT)
is a Sell
Phathom Pharmaceuticals Share Price Forecast
-
What is the Phathom Pharmaceuticals stock price today?The Phathom Pharmaceuticals stock price is 4.87 USD today.
-
Will PHAT stock go up or go down?Phathom Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Phathom Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Phathom Pharmaceuticals is overvalued.
Is Phathom Pharmaceuticals Stock a Buy?
-
Phathom Pharmaceuticals share price is 4.87 while PHAT 8-day exponential moving average is 5.38, which is a Sell signal.
-
The stock price of PHAT is 4.87 while Phathom Pharmaceuticals 20-day EMA is 5.61, which makes it a Sell.
-
Phathom Pharmaceuticals 50-day exponential moving average is 6.13 while PHAT share price is 4.87, making it a Sell technically.
-
PHAT stock price is 4.87 and Phathom Pharmaceuticals 200-day simple moving average is 9.12, creating a Sell signal.
Fundamental Analysis of Phathom Pharmaceuticals
Is Phathom Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.22 per share, an increase this year of $0.78 per share, and an increase next year of $2.19 per share.
Technical Analysis of Phathom Pharmaceuticals
Should I short Phathom Pharmaceuticals stock?
-
PHAT Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Phathom Pharmaceuticals is a Sell
-
Phathom Pharmaceuticals Relative Strength Index (RSI) is 40.69, which suggest Phathom Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Phathom Pharmaceuticals is (4.85 - 6.31), which suggest Phathom Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Phathom Pharmaceuticals is (5.06 - 9.36), which suggest Phathom Pharmaceuticals is a Sell
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.